Video Experimental Relacionado
Updated: Sep 10, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.7K
Exploración de la experiencia multidimensional de los síntomas en pacientes con enfermedad inflamatoria intestinal:
Yunzheng Di1,2, Xiaoping Zhu1, Yamei Chen1
1Department of Nursing, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Frontiers in medicine
|August 22, 2025
Resumen
Los pacientes con enfermedad inflamatoria intestinal (EII) enfrentan síntomas graves, con pérdida de peso y diarrea identificados como problemas centrales. La comprensión de estas relaciones de síntomas ayuda a desarrollar estrategias personalizadas de manejo para la EII.
Área de la Ciencia:
- Gastroenterología
- Investigación clínica
- Ciencia de los datos en medicina
Sus antecedentes:
- La enfermedad inflamatoria intestinal (EII) presenta una serie compleja de síntomas que afectan la calidad de vida del paciente.
- El manejo efectivo de la EII requiere una comprensión matizada de las interrelaciones de los síntomas.
- Las estrategias de tratamiento personalizadas son cruciales para abordar la carga diversa de síntomas en los pacientes con EII.
Objetivo del estudio:
- Explorar y visualizar las relaciones entre múltiples síntomas en pacientes con enfermedad inflamatoria intestinal (EII).
- Proporcionar evidencia empírica para el establecimiento de estrategias personalizadas y precisas de manejo de síntomas para la EII.
- Identificar los síntomas centrales y su centralidad dentro de la red de síntomas de la EII.
Principales métodos:
- Diseño de investigación correlacional cuantitativa que involucró a 324 pacientes hospitalizados con EII en Shanghai.
- Utilizó la Escala de Clusters de Síntomas para la Enfermedad Inflamatoria del Intestino (SCS-IBD) para la recopilación de datos.
- Se empleó regresión lineal múltiple y análisis de red simultáneo para examinar las relaciones entre los síntomas e identificar los síntomas centrales.
Principales resultados:
- La EII activa, la mayor duración del diagnóstico y la falta de medicación / cirugía se correlacionaron con un aumento de la gravedad de los síntomas.
- La fatiga fue el síntoma más frecuente y grave, pero la pérdida de peso y la diarrea mostraron una mayor centralidad de la red.
- La pérdida de peso y la diarrea se identificaron como síntomas principales en la red de síntomas de EII, independientemente de la inclusión de la covariante.
Conclusiones:
- Los pacientes con EII presentan una carga significativa y grave de síntomas.
- La pérdida de peso y la diarrea son síntomas centrales de la enfermedad inflamatoria intestinal, independientemente de otros factores.
- Los hallazgos apoyan el desarrollo de intervenciones específicas centradas en los síntomas centrales para mejorar el manejo de la EII.
Videos de Conceptos Relacionados
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
01:30Inflammatory Bowel Disease II: Crohn's Disease
382
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
382
01:17Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
245
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
245
01:29Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189